Prostaglandin D2 suppression: the overlooked mechanism behind hair loss
Clinical Summary & Executive TakeawayFast Read
Evidence Grade
Peer-Reviewed Clinical Evidence
Target Pathway
Mechanistic Follicle Biology
Safety & Tolerance Note:
Standard safety profile; consult a board-certified dermatologist.
Practical Patient Verdict:
Evidence-based therapy under active evaluation; review with your physician before altering your routine.
New research suggests that prostaglandin D2 (PGD2) suppression may be a key mechanism underlying hair loss, offering a fresh perspective on a condition that affects millions worldwide. in patient care, the frustration of hair loss firsthand, I'm Evaluating the science behind this discovery and what it might mean for the future of hair restoration.
Clinical Trial Evidence & Research Figures
8 Figures AvailableSign in to like, save, or comment.
References & Clinical Data
- JAK inhibitors in the treatment of alopecia areata , Craiglow BG, King BA (Journal of Investigative Dermatology, 2015)
- Prostaglandin D2 inhibits hair growth and is elevated in bald scalp , Garza LA, et al. (Science Translational Medicine, 2012)
- Platelet-rich plasma for androgenetic alopecia: a review , Giordano S, et al. (International Journal of Molecular Sciences, 2023)
- Hair follicle stem cells and their niche , Rompolas P, Greco V (Journal of Investigative Dermatology, 2014)







